186 related articles for article (PubMed ID: 23462228)
21. Effects of the cannabinoid CB1 receptor agonist CP55,940 and antagonist SR141716A on d-amphetamine-induced behaviours in Cebus monkeys.
Madsen MV; Peacock L; Werge T; Andersen MB
J Psychopharmacol; 2006 Sep; 20(5):622-8. PubMed ID: 16533866
[TBL] [Abstract][Full Text] [Related]
22. Cannabinoid-induced changes in respiration of brain mitochondria.
Fišar Z; Singh N; Hroudová J
Toxicol Lett; 2014 Nov; 231(1):62-71. PubMed ID: 25195527
[TBL] [Abstract][Full Text] [Related]
23. Opposing roles for cannabinoid receptor type-1 (CB₁) and transient receptor potential vanilloid type-1 channel (TRPV1) on the modulation of panic-like responses in rats.
Casarotto PC; Terzian AL; Aguiar DC; Zangrossi H; Guimarães FS; Wotjak CT; Moreira FA
Neuropsychopharmacology; 2012 Jan; 37(2):478-86. PubMed ID: 21937980
[TBL] [Abstract][Full Text] [Related]
24. Real-time characterization of cannabinoid receptor 1 (CB1 ) allosteric modulators reveals novel mechanism of action.
Cawston EE; Redmond WJ; Breen CM; Grimsey NL; Connor M; Glass M
Br J Pharmacol; 2013 Oct; 170(4):893-907. PubMed ID: 23937487
[TBL] [Abstract][Full Text] [Related]
25. Contrasting effects of different cannabinoid receptor ligands on mouse ingestive behaviour.
Grey J; Terry P; Higgs S
Behav Pharmacol; 2012 Sep; 23(5-6):551-9. PubMed ID: 22772336
[TBL] [Abstract][Full Text] [Related]
26. CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour.
Rubino T; Guidali C; Vigano D; Realini N; Valenti M; Massi P; Parolaro D
Neuropharmacology; 2008 Jan; 54(1):151-60. PubMed ID: 17692344
[TBL] [Abstract][Full Text] [Related]
27. Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice.
Gamble-George JC; Conger JR; Hartley ND; Gupta P; Sumislawski JJ; Patel S
Psychopharmacology (Berl); 2013 Aug; 228(3):401-9. PubMed ID: 23483200
[TBL] [Abstract][Full Text] [Related]
28. Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice.
Naderi N; Haghparast A; Saber-Tehrani A; Rezaii N; Alizadeh AM; Khani A; Motamedi F
Pharmacol Biochem Behav; 2008 Mar; 89(1):64-75. PubMed ID: 18096213
[TBL] [Abstract][Full Text] [Related]
29. Effects of the cannabinoid receptor ligands on anxiety-related effects of d-amphetamine and nicotine in the mouse elevated plus maze test.
Biala G; Kruk M; Budzynska B
J Physiol Pharmacol; 2009 Jun; 60(2):113-22. PubMed ID: 19617654
[TBL] [Abstract][Full Text] [Related]
30. Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner.
Zádor F; Lénárt N; Csibrány B; Sántha M; Molnár M; Tuka B; Samavati R; Klivényi P; Vécsei L; Marton A; Vizler C; Nagy GM; Borsodi A; Benyhe S; Páldy E
Neuropharmacology; 2015 Feb; 89():298-307. PubMed ID: 25446673
[TBL] [Abstract][Full Text] [Related]
31. Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission.
Rey AA; Purrio M; Viveros MP; Lutz B
Neuropsychopharmacology; 2012 Nov; 37(12):2624-34. PubMed ID: 22850737
[TBL] [Abstract][Full Text] [Related]
32. Involvement of M1 and CB₁ receptors in the anxiogenic-like effects induced by neostigmine injected into the rat prelimbic medial prefrontal cortex.
Fogaça MV; Fedoce AG; Ferreira-Junior NC; Guimarães FS; Resstel LB
Psychopharmacology (Berl); 2016 Apr; 233(8):1377-85. PubMed ID: 26873081
[TBL] [Abstract][Full Text] [Related]
33. Cannabinoid CB
Weresa J; Pędzińska-Betiuk A; Kossakowski R; Malinowska B
Pharmacol Rep; 2019 Feb; 71(1):82-89. PubMed ID: 30500553
[TBL] [Abstract][Full Text] [Related]
34. The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice.
Shafaroodi H; Samini M; Moezi L; Homayoun H; Sadeghipour H; Tavakoli S; Hajrasouliha AR; Dehpour AR
Neuropharmacology; 2004 Sep; 47(3):390-400. PubMed ID: 15275828
[TBL] [Abstract][Full Text] [Related]
35. Diet-dependent modulation of hippocampal expression of endocannabinoid signaling-related proteins in cannabinoid antagonist-treated obese rats.
Rivera P; Luque-Rojas MJ; Pastor A; Blanco E; Pavón FJ; Serrano A; Crespillo A; Vida M; Grondona JM; Cifuentes M; Bermúdez-Silva FJ; de la Torre R; de Fonseca FR; Suárez J
Eur J Neurosci; 2013 Jan; 37(1):105-17. PubMed ID: 23033907
[TBL] [Abstract][Full Text] [Related]
36. Mu-opioid and CB1 cannabinoid receptors of the dorsal periaqueductal gray interplay in the regulation of fear response, but not antinociception.
Godoi MM; Junior HZ; da Cunha JM; Zanoveli JM
Pharmacol Biochem Behav; 2020 Jul; 194():172938. PubMed ID: 32376258
[TBL] [Abstract][Full Text] [Related]
37. The interactive effects of verapamil and CB1 cannabinoid receptor antagonist/inverse agonist, AM251 on passive avoidance learning and memory in rat.
Karimi SA; Noorbakhsh M; Komaki H; Reza Nikoo M; Hasanein P; Shahidi S; Faraji N; Komaki A
Behav Pharmacol; 2022 Apr; 33(2&3):222-229. PubMed ID: 34845169
[TBL] [Abstract][Full Text] [Related]
38. ΔFosB induction correlates inversely with CB₁ receptor desensitization in a brain region-dependent manner following repeated Δ⁹-THC administration.
Lazenka MF; Selley DE; Sim-Selley LJ
Neuropharmacology; 2014 Feb; 77():224-33. PubMed ID: 24090766
[TBL] [Abstract][Full Text] [Related]
39. The cannabinoid system in the retrosplenial cortex modulates fear memory consolidation, reconsolidation, and extinction.
Sachser RM; Crestani AP; Quillfeldt JA; Mello E Souza T; de Oliveira Alvares L
Learn Mem; 2015 Dec; 22(12):584-8. PubMed ID: 26572648
[TBL] [Abstract][Full Text] [Related]
40. Disrupting the endocannabinoid system in early adolescence negatively impacts sociability.
Cossio D; Stadler H; Michas Z; Johnston C; Lopez HH
Pharmacol Biochem Behav; 2020 Jan; 188():172832. PubMed ID: 31778723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
